Endocrine Testing Market (Dehydroepiandrosterone Sulfate, Progesterone, Luteinizing Hormone, Estradiol, Human Chorionic Gonadotropin, Follicle Stimulating, Testosterone, Thyroid Prolactin, Thyroid Stimulating Hormone, Cortisol, Insulin, and Other Tests) By Technology (Monoclonal & Polyclonal Antibody Technologies, Tandem Mass Spectrometry, Immunoassay, Clinical Chemistry Technologies, and Others) for End-use Commercial Laboratories, Home-Based Tests, Ambulatory Care Centers, Hospitals and Other End-users: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 - 2021

Description

The report covers forecast and analysis for the endocrine testing market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the endocrine testing market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the endocrine testing market on a global level.

This report offers comprehensive coverage on global endocrine testing market along with, market trends, drivers and restraints of endocrine testing market. This report included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the endocrine testing market has also been included. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate and general attractiveness. This report is prepared using data sourced from in-house databases, secondary and primary research team of industry experts.

The study provides a decisive view on the endocrine testing market by segmenting the market based on test, technology, end-user and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The test market covered under this study includes Dehydroepiandrosterone sulfate (DHEAS), Progesterone, Luteinizing Hormone (LH), Estradiol (E2), Human Chorionic Gonadotropin (hCG), Follicle Stimulating (FSH), testosterone, thyroid prolactin, Thyroid Stimulating Hormone (TSH), cortisol, insulin, and other tests such as gastrin, thymosin, and secretin tests. Some of the key technologies in the market include monoclonal & polyclonal antibody technologies, tandem mass spectrometry, immunoassay, sensors, clinical chemistry technologies, and others. The end-users segmentation includes commercial laboratories, home-based tests, ambulatory care centers, hospitals and other. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global endocrine testing market include Bio Rad Laboratories, DiaSorin, Hoffmann-La Roche Ltd., LabCorp, and Quest Diagnostics, Abbott Laboratories, AB Sciex, Agilent Technologies, Biomedical Technologies and bioMerieux SA.

This report segments the global endocrine testing market as follows:

Global Endocrine Testing Market: Tests Segment Analysis

• Dehydroepiandrosterone sulfate (DHEAS)
• Progesterone
• Luteinizing Hormone (LH)
• Estradiol (E2)
• Human Chorionic Gonadotropin (hCG), Follicle Stimulating (FSH)
• Testosterone
• Thyroid prolactin
• Thyroid Stimulating Hormone (TSH), cortisol, insulin
• Other Test

Global Endocrine Testing Market: Technology Segment Analysis

• Monoclonal & Polyclonal Antibody Technologies
• Tandem Mass Spectrometry
• Immunoassay
• Sensors
• Clinical Chemistry Technologies
• Others

Global Endocrine Testing Market: End-user Segment Analysis

• Commercial Laboratories
• Home-Based Tests
• Ambulatory Care Centers
• Hospitals
• Other Healthcare Settings

Global Endocrine Testing Market: Regional Segment Analysis

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Table Of Content

• Chapter 1. Introduction
  • 1.1. Report Description And Scope
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology
• Chapter 2. Executive Summary
  • 2.1. Global Endocrine Testing Market, 2015 - 2021 (USD Million)
  • 2.2. Global Endocrine Testing Market: Snapshot
• Chapter 3. Endocrine Testing – Market Dynamics
  • 3.1. Introduction
  • 3.2. Market Drivers
    • 3.2.1. Global Endocrine testing Market Drivers: Impact Analysis
    • 3.2.2. Rising Diabetic and Obese Population
  • 3.3. Market Restraints
    • 3.3.1. Global Endocrine testing Market Restraints: Impact Analysis
    • 3.3.2. High Cost of Technology
  • 3.4. Opportunities
    • 3.4.1. Innovative Products
  • 3.5. Porter’s Five Forces Analysis
    • 3.5.1. Bargaining Power Of Suppliers
    • 3.5.2. Bargaining Power Of Buyers
    • 3.5.3. Threat From New Entrants
    • 3.5.4. Threat From New Substitutes
    • 3.5.5. Degree Of Competition
  • 3.6. Market Attractiveness Analysis
    • 3.6.1. Market Attractiveness Analysis, By Test Segment
    • 3.6.2. Market Attractiveness Analysis, By Technology Segment
    • 3.6.3. Market Attractiveness Analysis, By End-User Segment
    • 3.6.4. Market Attractiveness Analysis, By Regional Segment
• Chapter 4. Global Endocrine Testing Market – Competitive Landscape
  • 4.1. Company Market Share, 2015 (Subject To Data Availability)
  • 4.2. Strategic Development
    • 4.2.1. Acquisitions & Mergers
    • 4.2.2. New Type Launch
    • 4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures
    • 4.2.4. Research And Development, Regional Expansion
  • 4.3. Type Portfolio
• Chapter 5. Global Endocrine Testing Market – Test Analysis
  • 5.1. Global Endocrine Testing Market: Test Segment Overview
    • 5.1.1. Global Endocrine Testing Market Revenue Share, By Test, 2015 And 2021
  • 5.2. Dehydroepiandrosterone Sulfate
    • 5.2.1. Global Endocrine Testing Market for Dehydroepiandrosterone Sulfate, 2015 – 2021 (USD Million)
  • 5.3. Progesterone
    • 5.3.1. Global Endocrine Testing Market for Progesterone, 2015 – 2021 (USD Million)
  • 5.4. Luteinizing Hormone
    • 5.4.1. Global Endocrine Testing Market For Luteinizing Hormone, 2015 – 2021 (USD Million)
  • 5.5. Estradiol
    • 5.5.1. Global Endocrine Testing Market for Estradiol, 2015 – 2021 (USD Million)
  • 5.6. Human Chorionic Gonadotropin
    • 5.6.1. Global Endocrine Testing Market for Human Chorionic Gonadotropin, 2015 – 2021 (USD Million)
  • 5.7. Follicle Stimulating
    • 5.7.1. Global Endocrine Testing Market for Follicle Stimulating, 2015 – 2021 (USD Million)
  • 5.8. Testosterone
    • 5.8.1. Global Endocrine Testing Market for Testosterone, 2015 – 2021 (USD Million)
  • 5.9. Thyroid Prolactin
    • 5.9.1. Global Endocrine Testing Market for Thyroid Prolactin, 2015 – 2021 (USD Million)
  • 5.10. Thyroid Stimulating Hormone
    • 5.10.1. Global Endocrine Testing Market for Thyroid Stimulating Hormone, 2015 – 2021 (USD Million)
  • 5.11. Cortisol
    • 5.11.1. Global Endocrine Testing Market for Cortisol, 2015 – 2021 (USD Million)
  • 5.12. Insulin
    • 5.12.1. Global Endocrine Testing Market for Insulin, 2015 – 2021 (USD Million)
  • 5.13. Others
    • 5.13.1. Global Endocrine Testing Market for Other Test, 2015 – 2021 (USD Million)
• Chapter 6. Global Endocrine Testing Market – Technology Segment Analysis
  • 6.1. Global Endocrine testing Market: Technology Segment Overview
    • 6.1.1. Global Endocrine testing Market Revenue Share, By Technology, 2015 And 2021
  • 6.2. Monoclonal & Polyclonal Antibody Technologies
    • 6.2.1. Global Endocrine Testing Market For Monoclonal & Polyclonal Antibody Technologies, 2015 – 2021 (USD Million)
  • 6.3. Tandem Mass Spectrometry
    • 6.3.1. Global Endocrine Testing Market For Tandem Mass Spectrometry, 2015 – 2021 (USD Million)
  • 6.4. Immunoassay
    • 6.4.1. Global Endocrine Testing Market for Immunoassay, 2015 – 2021 (USD Million)
  • 6.5. Clinical Chemistry Technologies
    • 6.5.1. Global Endocrine Testing Market for Clinical Chemistry Technologies, 2015 – 2021 (USD Million)
  • 6.6. Other
    • 6.6.1. Global Endocrine Testing Market for Other Technologies, 2015 – 2021 (USD Million)
• Chapter 7. Global Endocrine Testing Market – End-User Segment Analysis
  • 7.1. Global Endocrine testing Market: End-User Segment Overview
    • 7.1.1. Global Endocrine testing Market Revenue Share, By End-User, 2015 And 2021
  • 7.2. Commercial Laboratories
    • 7.2.1. Global Endocrine Testing Market For Commercial Laboratories, 2015 – 2021 (USD Million)
  • 7.3. Home-Based Tests
    • 7.3.1. Global Endocrine Testing Market for Home-Based Tests 2015 – 2021 (USD Million)
  • 7.4. Ambulatory Care Centers
    • 7.4.1. Global Endocrine Testing Market for Ambulatory Care Centers 2015 – 2021 (USD Million)
  • 7.5. Hospitals
    • 7.5.1. Global Endocrine Testing Market for Hospitals 2015 – 2021 (USD Million)
  • 7.6. Other
    • 7.6.1. Global Endocrine Testing Market for other, 2015 – 2021 (USD Million)
• Chapter 8. Global Endocrine Testing Market – Regional Segment Analysis
  • 8.1. Global Endocrine Testing Market: Regional Overview
    • 8.1.1. Global Endocrine Testing Market Revenue Share, By Region, 2015 And 2021
  • 8.2. North America
    • 8.2.1. North America Endocrine Testing Market Revenue, By Test, 2015 – 2021 , (Usd Million)
    • 8.2.2. North America Endocrine Testing Market Revenue, By Technology, 2015 – 2021 , (USD Million)
    • 8.2.3. North America Endocrine Testing Market Revenue, By End-User Type, 2015 – 2021 , (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Endocrine Testing Market Revenue, By Test, 2015 – 2021 (USD Million)
    • 8.3.2. Europe Endocrine Testing Market Revenue, By Technology, 2015 – 2021 (USD Million)
    • 8.3.3. Europe Endocrine Testing Market Revenue, By End-User Type, 2015 – 2021 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Endocrine Testing Market Revenue, By Test, 2015 – 2021 (USD Million)
    • 8.4.2. Asia Pacific Endocrine Testing Market Revenue, By Technology, 2015 – 2021 (USD Million)
    • 8.4.3. Asia Pacific Endocrine Testing Market Revenue, By End-User Type, 2015 – 2021 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Endocrine Testing Market Revenue, By Test, 2015 – 2021 (USD Million)
    • 8.5.2. Latin America Endocrine Testing Market Revenue, By Technology, 2015 – 2021 (USD Million)
    • 8.5.3. Latin America Endocrine Testing Market Revenue, By End-User Type, 2015 – 2021 (USD Million)
  • 8.6. Middle East And Africa
    • 8.6.1. Middle East And Africa Endocrine Testing Market Revenue, By Test, 2015 – 2021 (USD Million)
    • 8.6.2. Middle East And Africa Endocrine Testing Market Revenue, By Technology, 2015 – 2021 (USD Million)
    • 8.6.3. Middle East And Africa Endocrine Testing Market Revenue, By End-User Type, 2015 – 2021 (USD Million)
• Chapter 9. Company Profile
  • 9.1. Abbott Laboratories
    • 9.1.1. Overview
    • 9.1.2. Financials
    • 9.1.3. Product Portfolio
    • 9.1.4. Business Strategy
    • 9.1.5. Recent Developments
  • 9.2. AB Sciex Pte.Ltd.
    • 9.2.1. Overview
    • 9.2.2. Financials
    • 9.2.3. Product Portfolio
    • 9.2.4. Business Strategy
    • 9.2.5. Recent Developments
  • 9.3. Agilent Technologies
    • 9.3.1. Overview
    • 9.3.2. Financials
    • 9.3.3. Product Portfolio
    • 9.3.4. Business Strategy
    • 9.3.5. Recent Developments
  • 9.4. Biomedical Technologies.
    • 9.4.1. Overview
    • 9.4.2. Financials
    • 9.4.3. Product Portfolio
    • 9.4.4. Business Strategy
    • 9.4.5. Recent Developments
  • 9.5. bioMerieux SA
    • 9.5.1. Overview
    • 9.5.2. Financials
    • 9.5.3. Product Portfolio
    • 9.5.4. Business Strategy
    • 9.5.5. Recent Developments
  • 9.6. Bio-Rad Laboratories.
    • 9.6.1. Overview
    • 9.6.2. Financials
    • 9.6.3. Product Portfolio
    • 9.6.4. Business Strategy
    • 9.6.5. Recent Developments
  • 9.7. DiaSorin S.p.A.
    • 9.7.1. Overview
    • 9.7.2. Financials
    • 9.7.3. Product Portfolio
    • 9.7.4. Business Strategy
    • 9.7.5. Recent Developments
  • 9.8. Hoffmann-La Roche Ltd.
    • 9.8.1. Overview
    • 9.8.2. Financials
    • 9.8.3. Product Portfolio
    • 9.8.4. Business Strategy
    • 9.8.5. Recent Developments
  • 9.9. Quest Technology
    • 9.9.1. Overview
    • 9.9.2. Financials
    • 9.9.3. Product Portfolio
    • 9.9.4. Business Strategy
    • 9.9.5. Recent Developments
  • 9.10. Thermo Fisher Scientific, Inc.
    • 9.10.1. Overview
    • 9.10.2. Financials
    • 9.10.3. Product Portfolio
    • 9.10.4. Business Strategy
    • 9.10.5. Recent Developments
  •  

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Endocrine Testing market. Zion Research has collected and analyzed key data belong to the global Endocrine Testing market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account while estimating market size. The revenue generated by the leading industry participants in from the sales of Endocrine Testing across the world has been calculated through primary and secondary research.

Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in the validation of findings from secondary research and to understand key trends in the Endocrine Testing industry. Primary research makes up the major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

• Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
• Helps in validating and strengthening the secondary research findings
• Further, develops the analysis team’s expertise and market understanding
• Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

• Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
• Purchasing managers, technical personnel, distributors and resellers
• Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

• Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
• IDC and other relevant magazines
• Internal and external proprietary databases, and relevant patent and regulatory databases
• National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Endocrine Testing market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

• Demographic data: Population split by segments
• Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
• Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
• Data is then cross-checked by an expert panel.

Free Analysis

The endocrine system is a very complex network that consists of several glands located throughout the body. Endocrine diagnostics test to measure the level of various hormones in a human body. It is also used to identify whether the endocrine glands are working properly. An optimally functioning endocrine system is essential to restoring and maintaining health.

Globally, the endocrine testing market has been accelerated on account of the rapid growth global geriatric population in both developed and developing countries. The changing lifestyles, increasing stress, and unhealthy food habits result in increased obesity and disturbed hormonal changes, which contributed substantially towards the growth of the endocrine diagnostics market. Moreover, increasing health awareness coupled with the government initiatives facilitated early diagnosis of endocrine disorders, which is expected to propel the demand for endocrine test kits. However, the high cost of technology is expected to be the major restraint for the growth of the endocrine testing market. Nonetheless, investment in research and technology is considered as a major opportunity for the growth of the global endocrine testing market.

The endocrine testing market can be segmented on the basis of test such as Dehydroepiandrosterone sulfate (DHEAS), Progesterone, Luteinizing Hormone (LH), Estradiol (E2), Human Chorionic Gonadotropin (hCG), Follicle Stimulating (FSH), testosterone, thyroid prolactin, Thyroid Stimulating Hormone (TSH), cortisol, insulin, and other tests such as gastrin, thymosin, and secretin tests. Thyroid stimulating hormone (TSH) was the leading segment owing to rising incidences of thyroid disorders and the growing awareness about the correlation between variations in the thyroid hormones levels and cardiovascular disorders. Insulin test is expected to witness the fastest growth in the years to come. This growth is mainly due to increase the rate of diabetes patients across the globe.

On the basis of technology, the market can be segmented into monoclonal & polyclonal antibody technologies, tandem mass spectrometry, immunoassay, sensors, clinical chemistry technologies, and others. Tandem mass spectrometry is expected to show significant growth in the years to come. Mass spectroscopy analysis is the most recent developed technology. The sensitivity of the tests by mass spectroscopy technology is very high.

Some of the key end-users include commercial laboratories, home-based tests, ambulatory care centers, hospitals and other healthcare settings. The commercial laboratories were the largest segment due to advanced infrastructure coupled with skilled personnel. The home-based test segment is growing fast with the introduction of new user-friendly and cost-effective diagnostic kits. This is expected to increase the penetration of home-based tests.

North America is projected to be the largest revenue contributing region. North America is expected to remain the dominant region over the next few years. Asia-Pacific is projected to be the fastest-growing region in the endocrine testing market during the forecast period as a result of demand from developing economies such as China and India. As a result of increasing aging population and increasing health awareness in Brazil, Latin America is also expected to experience significant growth in the years to come.

Some of the key players operating into this market include Bio Rad Laboratories, DiaSorin, Hoffmann-La Roche Ltd., LabCorp, Quest Diagnostics, Abbott Laboratories, AB Sciex, Agilent Technologies, Biomedical Technologies and bioMerieux SA.